Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 [Yahoo! Finance]
Aditxt, Inc. (ADTX)
Company Research
Source: Yahoo! Finance
— Forged commercial agreement for Phexxi in Middle East — SAN DIEGO Nov. 14, 2024 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results for the third quarter and nine-month period ended September 30, 2024 . Highlights include: Acquired global rights to SOLOSEC® (secnidazole) 2g oral granules , a single-dose oral antibiotic FDA approved to treat bacterial vaginosis and trichomoniasis, two common sexual health infections. Licensed Phexxi® (lactic acid, citric acid and potassium bitartrate) commercial rights in the Middle East to Emirati pharmaceutical company Pharma 1 Drug Store. The regulatory submission for the hormone-free contraceptive is on track for submission to the UAE Ministry of Health by year-end 2024. Launched a Market Development Collaboration with Pearsanta focused on its blood-based diagnostic test for endometriosis, a chronic disease associated with severe, life-impacting pai
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 [Yahoo! Finance]Yahoo! Finance
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]Canadian Business Journal
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025GlobeNewswire
- Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time [Yahoo! Finance]Yahoo! Finance
- Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern TimeBusiness Wire
ADTX
Sec Filings
- 1/27/25 - Form DEF
- 1/17/25 - Form PRER14A
- 1/13/25 - Form 8-K
- ADTX's page on the SEC website